Aliases & Classifications for Retinitis

MalaCards integrated aliases for Retinitis:

Name: Retinitis 12 55 15 73

Classifications:



External Ids:

Disease Ontology 12 DOID:3612
ICD10 33 H30.9
MeSH 44 D012173
NCIt 50 C115993
UMLS 73 C0035333

Summaries for Retinitis

MalaCards based summary : Retinitis is related to retinitis pigmentosa 2 and retinitis pigmentosa 28. An important gene associated with Retinitis is RPGR (Retinitis Pigmentosa GTPase Regulator). The drugs Cidofovir and Ganciclovir have been mentioned in the context of this disorder. Affiliated tissues include eye, retina and endothelial, and related phenotypes are nervous system and vision/eye

Wikipedia : 76 Retinitis is inflammation of the retina in the eye, which can permanently damage the retina and lead to... more...

Related Diseases for Retinitis

Diseases related to Retinitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 1570)
# Related Disease Score Top Affiliating Genes
1 retinitis pigmentosa 2 34.0 RP2 RPGR
2 retinitis pigmentosa 28 33.9 FAM161A FLVCR1
3 peripheral retinal degeneration 33.8 PRPH2 RPGR
4 retinitis pigmentosa 25 33.8 EYS RP9
5 retinitis pigmentosa 6 33.7 RHO RP9
6 retinitis pigmentosa 7 33.6 PRPH2 RHO RP9
7 fundus albipunctatus 33.5 PRPH2 RHO RLBP1
8 retinitis pigmentosa 9 33.5 IMPDH1 RP9
9 retinitis pigmentosa 10 33.2 IMPDH1 RHO RP9
10 retinitis pigmentosa 3 33.0 RPGR RPGRIP1
11 retinal disease 32.9 PRPH2 RHO RLBP1 RPGR RPGRIP1
12 retinal degeneration 32.8 PRPH2 RHO RLBP1 RPGR RPGRIP1
13 retinitis pigmentosa 1 32.6 IMPDH1 PRPH2 RHO RP1 RP1L1
14 usher syndrome, type iid 32.3 RHO RPGR
15 stargardt disease 32.1 EYS PRPH2 RHO RPGR
16 retinitis pigmentosa 18 32.1 IMPDH1 PRPF3 RP9
17 cone-rod dystrophy 2 32.0 CERKL EYS PRPH2 RHO RPGR RPGRIP1
18 retinitis pigmentosa 13 31.9 IMPDH1 PRPF3 RP9 RPGR
19 leber congenital amaurosis 31.4 IMPDH1 PRPH2 RHO RP2 RPGR RPGRIP1
20 laurence-moon syndrome 31.0 RPGR RPGRIP1
21 bestrophinopathy 30.3 PRPH2 RLBP1
22 stargardt macular degeneration 30.0 PRPH2 RHO
23 fundus dystrophy 29.9 CERKL EYS PRPH2 RHO RLBP1 RP1
24 retinitis pigmentosa 23.6 CERKL EYS FAM161A FLVCR1 IMPDH1 KLHL7
25 retinal detachment 12.3
26 retinitis pigmentosa 27 12.3
27 doyne honeycomb retinal dystrophy 12.2
28 retinitis pigmentosa 4 12.2
29 central retinal vein occlusion 12.2
30 retinitis pigmentosa 17 12.2
31 late-onset retinal degeneration 12.2
32 retinal dystrophy with inner retinal dysfunction and ganglion cell abnormalities 12.2
33 retinitis pigmentosa 45 12.2
34 central retinal artery occlusion 12.2
35 retinitis pigmentosa 12 12.2
36 retinitis pigmentosa-deafness syndrome 12.2
37 neuropathy, ataxia, and retinitis pigmentosa 12.2
38 cytomegalovirus retinitis 12.1
39 retinitis pigmentosa 50 12.1
40 posterior column ataxia with retinitis pigmentosa 12.1
41 retinal arteries, tortuosity of 12.1
42 infantile cerebellar-retinal degeneration 12.1
43 retinitis pigmentosa 41 12.1
44 retinitis pigmentosa 67 12.1
45 retinitis pigmentosa 11 12.1
46 retinal arterial macroaneurysm with supravalvular pulmonic stenosis 12.1
47 vasculopathy, retinal, with cerebral leukodystrophy 12.1
48 retinitis pigmentosa 38 12.1
49 retinitis pigmentosa 14 12.1
50 retinitis pigmentosa 19 12.1

Graphical network of the top 20 diseases related to Retinitis:



Diseases related to Retinitis

Symptoms & Phenotypes for Retinitis

MGI Mouse Phenotypes related to Retinitis:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 nervous system MP:0003631 9.85 RHO RLBP1 RP1 RP1L1 RP2 RPGR
2 vision/eye MP:0005391 9.44 RLBP1 RP1 RP1L1 RP2 RPGR RPGRIP1
3 pigmentation MP:0001186 9.43 RHO RLBP1 RPGR SEMA4A PRPF3 PRPH2

Drugs & Therapeutics for Retinitis

Drugs for Retinitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 238)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Cidofovir Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 113852-37-2 60613
2
Ganciclovir Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 82410-32-0 3454
3
Foscarnet Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 63585-09-1, 4428-95-9 3415
4
Probenecid Approved, Investigational Phase 4,Phase 2,Phase 1,Not Applicable 57-66-9 4911
5
Phosphonoacetic Acid Experimental Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 4408-78-0 546
6 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
7 Antirheumatic Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
8 Antiviral Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
9 Ganciclovir triphosphate Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
10 Nucleic Acid Synthesis Inhibitors Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
11 Anti-Retroviral Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
12 Reverse Transcriptase Inhibitors Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
13 Renal Agents Phase 4,Phase 2,Phase 1,Not Applicable
14
Valganciclovir Approved, Investigational Phase 3,Not Applicable 175865-60-8 64147
15
Eplerenone Approved Phase 2, Phase 3 107724-20-9 150310 443872
16
Spironolactone Approved Phase 2, Phase 3,Phase 1 1952-01-7, 52-01-7 5833
17
Clindamycin Approved, Vet_approved Phase 3 18323-44-9 29029
18
Dexamethasone Approved, Investigational, Vet_approved Phase 3,Phase 2 50-02-2 5743
19
Methylprednisolone Approved, Vet_approved Phase 3 83-43-2 6741
20
Prednisolone Approved, Vet_approved Phase 3 50-24-8 5755
21
Pyrimethamine Approved, Investigational, Vet_approved Phase 3 58-14-0 4993
22
Sulfadiazine Approved, Investigational, Vet_approved Phase 3 68-35-9 5215
23
Acyclovir Approved Phase 3,Not Applicable 59277-89-3 2022
24
Celecoxib Approved, Investigational Phase 3 169590-42-5 2662
25
Folic Acid Approved, Nutraceutical, Vet_approved Phase 3,Phase 1,Phase 2,Early Phase 1 59-30-3 6037
26
leucovorin Approved, Nutraceutical Phase 3,Phase 1,Phase 2 58-05-9 143 6006
27
Lutein Approved, Investigational, Nutraceutical Phase 3,Phase 1,Phase 2 127-40-2 6433159
28
Vitamin A Approved, Nutraceutical, Vet_approved Phase 3,Phase 1 11103-57-4, 68-26-8 445354
29
Vitamin D Approved, Nutraceutical, Vet_approved Phase 3 1406-16-2
30
Tocopherol Approved, Investigational, Nutraceutical Phase 3 1406-66-2 14986
31
Vitamin E Approved, Nutraceutical, Vet_approved Phase 3 59-02-9 14985
32
Beta carotene Approved, Nutraceutical Phase 2, Phase 3,Phase 1 7235-40-7
33 diuretics Phase 2, Phase 3,Phase 1
34 Diuretics, Potassium Sparing Phase 2, Phase 3,Phase 1
35 Hormone Antagonists Phase 2, Phase 3,Phase 3,Phase 1
36 Hormones Phase 2, Phase 3,Phase 3,Phase 1
37 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 2, Phase 3,Phase 3,Phase 1
38 Mineralocorticoid Receptor Antagonists Phase 2, Phase 3,Phase 1
39 Mineralocorticoids Phase 2, Phase 3,Phase 1
40 Natriuretic Agents Phase 2, Phase 3,Phase 1
41 Anti-Bacterial Agents Phase 3,Phase 1,Phase 2,Not Applicable
42 Antiemetics Phase 3,Phase 2
43 Anti-Inflammatory Agents Phase 3,Phase 2,Not Applicable
44 Antimalarials Phase 3
45 Antineoplastic Agents, Hormonal Phase 3,Phase 2
46 Antiparasitic Agents Phase 3
47 Antiprotozoal Agents Phase 3
48 Autonomic Agents Phase 3,Phase 2,Phase 1
49 BB 1101 Phase 3,Phase 2
50 Clindamycin palmitate Phase 3

Interventional clinical trials:

(show top 50) (show all 243)
# Name Status NCT ID Phase Drugs
1 Comparison of Two Drugs, Cidofovir and Ganciclovir, in Treating Patients With AIDS Who Have CMV Retinitis Completed NCT00000894 Phase 4 Cidofovir;Probenecid;Ganciclovir
2 The Role of Capsular Tension Ring (CTR) in Anterior Capsular Contraction Completed NCT00717080 Phase 4
3 A Multicenter Study of Oral Versus Intravenous Hydration in AIDS Patients With CMV Retinitis Treated With Foscavir (Foscarnet Sodium) Completed NCT00002125 Phase 4 Foscarnet sodium
4 Pharmacokinetics of Cidofovir During Continuous Venovenous Hemofiltration Completed NCT01866397 Phase 4
5 Use of Cidofovir for Recurrent Respiratory Papillomatosis Completed NCT00205374 Phase 4 Cidofovir;Placebo
6 Valganciclovir in Patients With CMV Retinitis and AIDS Who Cannot Take Drugs by Injection Unknown status NCT00017784 Phase 3 Valganciclovir
7 A Study of the Beneficial Effects of Eplerenone on Central Serous Chorioretinopathy Unknown status NCT02215330 Phase 2, Phase 3 Eplerenone;Maltodextrin
8 To Compare Intravitreal Clindamycin & Dexamethasone With Classic Treatment of Toxoplasmic Retinochoroiditis Unknown status NCT00372294 Phase 3 pyrimethamine-sulfadiazine + prednisolone;Clindamycin+Dexamethasone
9 Clinical Trial of Lutein for Patients With Retinitis Pigmentosa Receiving Vitamin A Completed NCT00346333 Phase 3 Lutein
10 Studies of the Ocular Complications of AIDS (SOCA)--HPMPC Peripheral CMV Retinitis Trial (HPCRT) Completed NCT00000142 Phase 2, Phase 3 Cidofovir
11 Studies of the Ocular Complications of AIDS (SOCA)--Monoclonal Antibody CMV Retinitis Trial (MACRT) Completed NCT00000135 Phase 2, Phase 3 MSL-109
12 Randomized Trial for Retinitis Pigmentosa Completed NCT00000116 Phase 3 Vitamin A;Nutritional Supplement
13 A Randomized, Controlled Study of Intravenous Ganciclovir Therapy for Peripheral Cytomegalovirus Retinitis in Patients With AIDS Completed NCT00000688 Phase 3 Ganciclovir
14 Studies of the Ocular Complications of AIDS (SOCA)--Cytomegalovirus Retinitis Retreatment Trial (CRRT) Completed NCT00000134 Phase 3 Ganciclovir;Foscarnet
15 A Treatment Protocol for the Use of Intravenous Ganciclovir in AIDS Patients With Immediately Sight-Threatening CMV Retinitis Completed NCT00000698 Phase 3 Ganciclovir
16 Phase III Ganciclovir +/- rGM-CSF for AIDS-Related CMV Retinitis Completed NCT00002070 Phase 3 Sargramostim;Ganciclovir
17 Studies of the Ocular Complications of AIDS (SOCA)--Foscarnet-Ganciclovir CMV Retinitis Trial (FGCRT) Completed NCT00000136 Phase 3 Foscarnet;Ganciclovir
18 Studies of Ocular Complications of AIDS (SOCA)--Ganciclovir-Cidofovir CMV Retinitis Trial (GCCRT) Completed NCT00000143 Phase 3 Cidofovir intravenous
19 Randomized Trial of Vitamin A and Vitamin E Supplementation for Retinitis Pigmentosa Completed NCT00000114 Phase 3 Vitamin E;Vitamin A
20 Ganciclovir Implant Study for Cytomegalovirus Retinitis Completed NCT00000118 Phase 3
21 A Comparison of Valganciclovir and Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes Completed NCT00002377 Phase 3 Valganciclovir;Ganciclovir
22 Valganciclovir in Prevention of Cytomegalovirus (CMV) Reactivation Following Allogeneic-Stem Cell Transplantation (SCT) Completed NCT00330018 Phase 3 Valganciclovir;Acyclovir
23 Ozurdex for Macular Edema Post Membrane Peeling Completed NCT01273727 Phase 2, Phase 3 Dexamethasone;dexamethasone
24 Laser and Medical Treatment of Diabetic Macular Edema Completed NCT00050479 Phase 3 Celecoxib (Celebrex)
25 Letermovir (MK-8228) Versus Placebo in the Prevention of Clinically-Significant Cytomegalovirus (CMV) Infection in Adult, CMV-Seropositive Allogeneic Hematopoietic Stem Cell Transplant Recipients (MK-8228-001) Completed NCT02137772 Phase 3 Letermovir;Placebo
26 The Effect of Oral Administration of 9-cis β Carotene Rich Powder of the Alga Dunaliella Bardawil Recruiting NCT01680510 Phase 2, Phase 3
27 Setmelanotide Phase 2 Treatment Trial in Patients With Rare Genetic Disorders of Obesity Recruiting NCT03013543 Phase 2, Phase 3 Setmelanotide
28 Safety and Efficacy Study in Subjects With Leber Congenital Amaurosis Active, not recruiting NCT00999609 Phase 3
29 Open-Label Rollover Study of PBI 4050 in Subjects With Alström Syndrome Enrolling by invitation NCT03184584 Phase 2, Phase 3 PBI-4050
30 Phase III Efficacy and Safety Clinical Study of UF-021 for Treatment of Retinitis Pigmentosa Terminated NCT01786395 Phase 3 UF-021;Placebo
31 Clinical Study to Evaluate Safety and Efficacy of BMMNC in Retinitis Pigmentosa Unknown status NCT01914913 Phase 1, Phase 2
32 Intravitreal Dexamethasone Implant in Retinitis Pigmentosa-related Macular Edema- a Retrospective Study Unknown status NCT02804360 Phase 2
33 A Dose Ranging Study to Evaluate the Safety and Potential Efficacy of rhNGF in Patients With Retinitis Pigmentosa (RP) Unknown status NCT02110225 Phase 1, Phase 2 rhNGF 60 µg/ml eye drops solution;rhNGF 180 µg/ml eye drops solution;Placebo
34 Autologous Bone Marrow-Derived Stem Cells Transplantation For Retinitis Pigmentosa Completed NCT01560715 Phase 2
35 Trial of Oral Valproic Acid for Retinitis Pigmentosa Completed NCT01233609 Phase 2 Valproic Acid;Placebo
36 Study of Oral Minocycline in Treating Bilateral Cystoid Macular Edema Associated With Retinitis Pigmentosa Completed NCT02140164 Phase 1, Phase 2 Minocycline
37 A Study of Encapsulated Cell Technology (ECT) Implant for Patients With Late Stage Retinitis Pigmentosa Completed NCT00447993 Phase 2 NT-501;NT-501
38 Safety of a Single, Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Retinitis Pigmentosa Completed NCT02320812 Phase 1, Phase 2
39 Safety Study in Retinal Transplantation for Retinitis Pigmentosa. Completed NCT00345917 Phase 2
40 A Study of Encapsulated Cell Technology (ECT) Implant for Participants With Early Stage Retinitis Pigmentosa Completed NCT00447980 Phase 2 NT-501;NT-501
41 CMV Retinitis Retreatment Trial Completed NCT00000766 Phase 2 Foscarnet sodium;Ganciclovir
42 Nerve Growth Factor Eye Drops Treatment in Patients With Retinitis Pigmentosa and Cystoid Macular Edema Completed NCT02609165 Phase 2 rhNGF 180 µg/ml eye drops solution;vehicle eye drops
43 Effects of Lutein in Retinitis Pigmentosa Completed NCT00029289 Phase 1, Phase 2 Lutein (10 or 30 mg/day) capsules
44 A Randomized Comparison of Intravitreal ISIS 2922 Plus Ganciclovir Versus Ganciclovir as Treatment for Patients With Cytomegalovirus Retinitis ( CMVR ) Completed NCT00002156 Phase 2 Fomivirsen sodium;Ganciclovir
45 A Study of Viracept in AIDS Patients With Cytomegalovirus Retinitis Completed NCT00002169 Phase 2 Nelfinavir mesylate
46 DHA and X-Linked Retinitis Pigmentosa Completed NCT00100230 Phase 2 docosahexaenoic acid OR corn/soy oil placebo
47 A Phase II Dose-Ranging, Open-Labelled Trial of Foscarnet Salvage Therapy for AIDS Patients With Sight-Threatening CMV Retinitis Who Cannot Be Treated With Ganciclovir Due To Myelosuppression or Treatment Failure Completed NCT00000691 Phase 2 Foscarnet sodium
48 An Exploratory Study to Evaluate the Safety of Brimonidine Intravitreal Implant in Patients With Retinitis Pigmentosa Completed NCT00661479 Phase 1, Phase 2 400 µg Brimonidine Tartrate Implant;200 µg Brimonidine Tartrate Implant;100 µg Brimonidine Tartrate Implant
49 Phase II Randomized Study of Cidofovir for Peripheral Cytomegalovirus Retinitis Completed NCT00004794 Phase 2 cidofovir
50 The Safety and Effectiveness of ISIS 2922 in Patients With AIDS Who Have Cytomegalovirus (CMV) of the Eyes Completed NCT00002356 Phase 2 Fomivirsen sodium

Search NIH Clinical Center for Retinitis

Genetic Tests for Retinitis

Anatomical Context for Retinitis

MalaCards organs/tissues related to Retinitis:

41
Eye, Retina, Endothelial, Bone, Testes, T Cells, Brain

Publications for Retinitis

Articles related to Retinitis:

(show top 50) (show all 13425)
# Title Authors Year
1
Central retinal vein occlusion in temporal arteritis: red sign or red herring? ( 29361164 )
2018
2
ILM peeling in macular hole retinal detachment: insert or not? ( 29909575 )
2018
3
The P2Y<sub>12</sub> Receptor Antagonist Ticagrelor Reduces Lysosomal pH and Autofluorescence in Retinal Pigmented Epithelial Cells From the ABCA4<sup>-/-</sup> Mouse Model of Retinal Degeneration. ( 29725296 )
2018
4
Accuracy of axial length measurements obtained by optical biometry and acoustic biometry in rhegmatogenous retinal detachment: a prospective study. ( 29872256 )
2018
5
Cadherins in the retinal pigment epithelium (RPE) revisited: P-cadherin is the highly dominant cadherin expressed in human and mouse RPE in vivo. ( 29338041 )
2018
6
Effects of Dexamethasone Implant on Multifocal Electroretinography in Central Retinal Vein Occlusion. ( 29403585 )
2018
7
Two-year progression analysis of RPE65 autosomal dominant retinitis pigmentosa. ( 29947567 )
2018
8
Spectral domain optical coherence tomography and fundus autofluorescence findings in cytomegalovirus retinitis in HIV-infected patients. ( 29445945 )
2018
9
Autologous stem cell therapy for inherited and acquired retinal disease. ( 29360008 )
2018
10
Central Retinal Artery Occlusion with Cilioretinal Artery sparing; imaging by smartphone. ( 29921543 )
2018
11
Characterization of Retinitis Pigmentosa Using Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO). ( 29946494 )
2018
12
Comparison of 5-year progression of retinitis pigmentosa involving the posterior pole among siblings by means of SD-OCT: a retrospective study. ( 29940899 )
2018
13
Quantification of Macular Microvascular Changes in Patients With Retinitis Pigmentosa Using Optical Coherence Tomography Angiography. ( 29365150 )
2018
14
Knockdown of survivin results in inhibition of epithelial to mesenchymal transition in retinal pigment epithelial cells by attenuating the TGFI^ pathway. ( 29522718 )
2018
15
YC-1 Inhibits VEGF and Inflammatory Mediators Expression on Experimental Central Retinal Vein Occlusion in Rhesus Monkey. ( 29364731 )
2018
16
Clinicopathologic Correlation of a Subretinal Proliferative Vitreoretinopathy Band in a Patient with Chronic Recurrent Retinal Detachment. ( 29928223 )
2018
17
An Assessment of Retinal Nerve Fiber Layer Thickness in Non-Diabetic Obese Children and Adolescents. ( 28739552 )
2018
18
Retinal Neuronal Loss in Visually Asymptomatic Patients With Myoclonic Epilepsy With Ragged-Red Fibers. ( 29979334 )
2018
19
PERIPHERAL RETINAL DRUSEN-LIKE DEPOSITS IN GUCY2C CONGENITAL SECRETORY DIARRHEA SYNDROME. ( 29979251 )
2018
20
Predicting the visual acuity for retinal vein occlusion after ranibizumab therapy with an original ranking for macular microstructure. ( 29399095 )
2018
21
A novel small molecule chaperone of rod opsin and its potential therapy for retinal degeneration. ( 29773803 )
2018
22
Carotid ergotism with retinal ischemia. ( 29708216 )
2018
23
Optical coherence tomography angiography of the macular microvasculature changes in retinitis pigmentosa. ( 28561452 )
2018
24
Superficial and deep retinal foveal avascular zone OCTA findings of non-infectious anterior and posterior uveitis. ( 29980918 )
2018
25
TRPV4 regulates migration and tube formation of human retinal capillary endothelial cells. ( 29433476 )
2018
26
Protective effects of 6-ureido/thioureido-2,4,5-trimethylpyridin-3-ols against 4-hydroxynonenal-induced cell death in adult retinal pigment epithelial-19 cells. ( 29208521 )
2018
27
Retinal vasculitis and Eales disease. ( 29599058 )
2018
28
Expanded Retinal Disease Spectrum Associated With Autosomal Recessive Mutations in GUCY2D. ( 29559409 )
2018
29
Incidence of retinal vein occlusion in open-angle glaucoma: a nationwide, population-based study using the Korean Health Insurance Review and Assessment Database. ( 29360215 )
2018
30
Association of retinal nerve fibre layer thickness with quantitative magnetic resonance imaging data of the optic chiasm in pituitary adenoma patients. ( 29398198 )
2018
31
A 5-Year Follow-Up Study of the Treatment of Macular Edema Due to Retinal Vein Occlusion Using Dexamethasone Intravitreal Implants. ( 29708803 )
2018
32
Retinal pigment epithelium changes in Kartagener syndrome. ( 29511746 )
2018
33
Retinal detachment after acute posterior vitreous detachment resulting from posterior chamber phakic intraocular lens implantation. ( 29502596 )
2018
34
Pharmacotherapy of retinal disease with visual cycle modulators. ( 29542350 )
2018
35
Retinal vein occlusion associated with combined hormonal contraceptive vaginal ring use. ( 29862193 )
2018
36
ERGs on the brain: the benefits of simultaneous flash retinal and cortical responses in paediatric cerebral visual impairment. ( 29725862 )
2018
37
Efficacy of adalimumab and infliximab in recalcitrant retinal vasculitis inadequately responsive to other immunomodulatory therapies. ( 29766375 )
2018
38
Nonaccidental injury presenting as unilateral Retinal Detachment in two infants. ( 29410140 )
2018
39
Inhibition of non-NMDA ionotropic glutamate receptors delays the retinal degeneration in rd10 mouse. ( 29940208 )
2018
40
Olfactory Dysfunction in Patients With CNGB1-Associated Retinitis Pigmentosa. ( 29800053 )
2018
41
Phenotypic expansion and progression of SPATA7-associated retinitis pigmentosa. ( 29411205 )
2018
42
Evaluation of efficacy of infliximab for retinal vasculitis and extraocular symptoms in BehAset disease. ( 29582190 )
2018
43
Inverted internal limiting membrane insertion versus standard internal limiting membrane peeling for macular hole retinal detachment in high myopia: one-year study. ( 29911271 )
2018
44
Cytomegalovirus retinitis before and after treatment. ( 29776766 )
2018
45
Toxoplasma gondii bradyzoites and tachyzoites isolation from vitreous of atypical necrotizing retinitis. ( 29904801 )
2018
46
Primary Cilium-Mediated Retinal Pigment Epithelium Maturation Is Disrupted in Ciliopathy Patient Cells. ( 29298421 )
2018
47
Epidemic Retinitis. ( 29370564 )
2018
48
Six Years and Counting: Restoration of Photopic Retinal Function and Visual Behavior Following Gene Augmentation Therapy in a Sheep Model of CNGA3 Achromatopsia. ( 29926749 )
2018
49
Bilateral central retinal artery occlusion as presenting manifestation of human immunodeficiency virus infection. ( 29480272 )
2018
50
Patients and animal models of CNGI^1-deficient retinitis pigmentosa support gene augmentation approach. ( 29202463 )
2018

Variations for Retinitis

Expression for Retinitis

Search GEO for disease gene expression data for Retinitis.

Pathways for Retinitis

GO Terms for Retinitis

Cellular components related to Retinitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cell projection GO:0042995 9.85 FAM161A RHO RP1 RP2 RPGR RPGRIP1
2 cilium GO:0005929 9.72 FAM161A RP1 RP2 RPGR RPGRIP1
3 axoneme GO:0005930 9.58 RP1 RP1L1 RPGRIP1
4 ciliary basal body GO:0036064 9.56 FAM161A RP2 RPGR TOPORS
5 photoreceptor inner segment GO:0001917 9.46 CERKL FAM161A RHO RP1
6 U4/U6 x U5 tri-snRNP complex GO:0046540 9.43 PRPF3 SNRNP200
7 photoreceptor connecting cilium GO:0032391 9.35 FAM161A RP1 RP1L1 RPGRIP1 TOPORS
8 photoreceptor outer segment GO:0001750 9.1 CERKL PRPH2 RHO RP1 RP1L1 RPGR

Biological processes related to Retinitis according to GeneCards Suite gene sharing:

(show all 12)
# Name GO ID Score Top Affiliating Genes
1 response to stimulus GO:0050896 9.7 EYS FAM161A RHO RLBP1 RP1 RPGR
2 cell projection organization GO:0030030 9.69 FAM161A RP1 RPGR
3 photoreceptor cell maintenance GO:0045494 9.5 RHO RP1 RP1L1
4 axoneme assembly GO:0035082 9.49 RP1 RP1L1
5 cellular response to light stimulus GO:0071482 9.48 RHO RP1
6 retinal rod cell development GO:0046548 9.46 RP1 TOPORS
7 retinal cone cell development GO:0046549 9.43 RP1 TOPORS
8 photoreceptor cell outer segment organization GO:0035845 9.4 RP1 TOPORS
9 phototransduction, visible light GO:0007603 9.37 RHO RP1
10 retina development in camera-type eye GO:0060041 9.35 PRPH2 RHO RP1 RP1L1 RPGRIP1
11 visual perception GO:0007601 9.32 EYS FAM161A PRPH2 RHO RLBP1 RP1
12 photoreceptor cell development GO:0042461 9.26 RP1 RP1L1

Molecular functions related to Retinitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 11-cis retinal binding GO:0005502 8.62 RHO RLBP1

Sources for Retinitis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....